Altria Group, Inc. is a prominent U.S.-based manufacturer and distributor of tobacco products, with a portfolio encompassing iconic brands like Marlboro cigarettes and Black & Mild cigars, alongside smokeless tobacco products and oral nicotine pouches. Operating within the Consumer Defensive sector, specifically the Tobacco industry, Altria's business is characterized by its established presence in the domestic market and a focus on traditional tobacco offerings. The company's historical performance shows a mixed but generally positive trend in earnings per share (EPS) and revenue. In the most recent reported quarters, Q4 2025 saw EPS of $1.30 against an estimate of $1.3575, and revenue of $5.079 billion against an estimate of $5.19 billion, indicating a miss on both fronts. This followed Q3 2025 where EPS was $1.45, beating the estimate of $1.44818, and revenue was $5.251 billion (no estimate provided). Prior to this, Q2 2025 reported EPS of $1.44 versus an estimate of $1.3848, and Q1 2025 reported EPS of $1.23 against an estimate of $1.18813. This pattern suggests recent quarters have seen a return to EPS beats after a miss in Q4 2025, with revenue data availability being limited for earlier periods. Historically, Altria has demonstrated a strong ability to grow revenue year-over-year, often accompanied by EPS beats, though the most recent quarter showed a deviation from this trend. Recent news highlights significant multi-year share price appreciation and strong gross margins averaging 87.1%, indicating robust pricing power and excellent free cash flow generation. Investors will be watching for continued EPS beats in upcoming quarters, particularly as the company navigates market dynamics and potential regulatory shifts, and how its strong fundamental strengths translate into sustained financial performance against analyst expectations.
